Endovascular Treatment for Stroke Due to Occlusion of Medium or Distal Vessels
University of Basel · University Hospital of Basel · +52 more institutions
Abstract
Endovascular treatment (EVT) of stroke with large-vessel occlusion is known to be safe and effective. The effect of EVT for occlusion of medium or distal vessels is unclear.
We randomly assigned participants with an isolated occlusion of medium or distal vessels (occlusion of the nondominant or codominant M2 segment of the middle cerebral artery [MCA]; the M3 or M4 segment of the MCA; the A1, A2, or A3 segment of the anterior cerebral artery; or the P1, P2, or P3 segment of the posterior cerebral artery) to receive EVT plus best medical treatment or best medical treatment alone within 24 hours after the participant was last seen to be well. The primary outcome was the level of disability at 90 days, as assessed with the modified Rankin scale score.
Citation impact
- FWCI
- 199.72
- Percentile
- 100%
- References
- 16
Authors
63- MPMarios‐Nikos PsychogiosCorresponding
University of Basel, University Hospital of Basel
- ABAlex Brehm
University Hospital of Basel
- MRMarc Ribó
Universitat Autònoma de Barcelona, Vall d'Hebron Hospital Universitari
- FRFederica Rizzo
Universitat Autònoma de Barcelona, Vall d'Hebron Hospital Universitari
- DSDaniel Strbian
University of Helsinki, Helsinki University Hospital
Topics & keywords
- Occlusion
- Stroke (engine)
- Endovascular treatment
- Medicine
- Cardiology
- Internal medicine
- Radiology
- Engineering
- Good health and well-being
Funding
- UOUniversity of Bern
- HMHaaglanden Medisch Centrum
- PPenumbra
- UHUniversität Heidelberg
- SNSchweizerischer Nationalfonds zur Förderung der Wissenschaftlichen ForschungAward: 33IC30_198783
- UMUniversiteit Maastricht
- UZUniversitair Ziekenhuis Gent
- HUHebrew University of Jerusalem
- UGUniversiteit Gent
- MUMaastricht Universitair Medisch Centrum
- NANational and Kapodistrian University of Athens
- GUGottfried und Julia Bangerter-Rhyner-Stiftung
- HUHôpitaux Universitaires de Genève
- RARWTH Aachen University
- CFCenter for Stroke Research Berlin
- UOUniversity of California, Los Angeles
- DGDavid Geffen School of Medicine, University of California, Los Angeles